The above results suggest that STAT3 blockade could not only decrease non-CSC cancer cells but also reduce CSCs through self-renewal transcription factors, indicating STAT3 blockade can truly inhibit CSCs phenotype with small molecule inhibitor S3I-201. This evidence concerns the gene STAT3 and cancer.